Morning Briefing
Summaries of health policy coverage from major news organizations
Viewpoints: Measles Resurgence Is Just The Beginning; Potential Pancreatic Cancer Vaccine Shows Promise
Reversing the new vaccine skepticism will require a dedicated effort. (4/25)
One of the deadliest known cancers pancreas cancer may be far more treatable thanks to mRNA vaccines. (4/24)
Last December, news broke that the Centers for Disease Control and Prevention had awarded $1.6 million to a Danish vaccine research group to study the effects of the hepatitis B vaccine on infants in the West African nation of Guinea-Bissau. The proposed five-year study compared outcomes between infants vaccinated at birth and those vaccinated at six weeks of age. As a medical student and researcher, I was shocked by the brazen inequity of the trial.(Uzma Rentia, 4/27)
On Monday, the Supreme Court is set to hear oral arguments in Monsanto Company v. Durnell. John Durnell, a Missouri man who developed non-Hodgkins lymphoma, is arguing that glyphosates manufacturer, Monsanto, failed to warn users of the chemicals danger. (Dan Blaustein-Rejto, 4/25)
As I read over an employment contract for a job as a psychiatric nurse practitioner, one clause stopped me cold. If I left the practice, Id owe $7,500 for every patient who chose to continue treatment with me. When I questioned the clause, the response came quickly, with irritation: The practice owns the patients. You do not. (Sarah Cady, 4/27)